Compliance
RSSArticles
-
Nurses Suspended for Viewing Patient’s Genitals
Denver Health Medical Center suspended five nurses for three weeks after confirming they intentionally viewed a patient’s genitals without cause, including opening his body bag to view the deceased man’s body parts.
-
Copy-and-Paste Brings Compliance Risks
Physicians can create compliance risks by overusing copy-and-paste in electronic medical records. The records can result in upcoding and the loss of reimbursement.
-
Hospital Loses Tax-exempt Status Over 501(r)
The IRS has revoked the tax-exempt status of a hospital for noncompliance with section 501(r) of the Internal Revenue Code, following the lead of state tax courts that have been increasingly harsh when scrutinizing tax-exempt hospitals.
-
Family Sues Nurse and Hospital After Newborn Death
An Oregon woman is suing Portland Adventist Medical Center and an individual nurse after her four-day-old son died. Monica Thompson is seeking $3.5 million from the nurse and $5.1 million from the hospital.
-
Smothered Newborn Shows Patient Safety, Liability Risks
A tragic newborn death illustrates the patient safety risks posed by simply leaving an infant to sleep in the arms of its mother, risks that are increasing with the emphasis on more physical contact between the mother and child.
-
Study: Trial Results for New Neurological Drugs Often Go Unpublished
Results of clinical trials for “stalled” neurological drugs — those which had at least one completed Phase III trial but failed to receive FDA approval — are heavily underreported, found a new study.
-
AllTrials Seeks Transparency in Big Pharma Studies
The AllTrials campaign, striving to achieve full disclosure of all results in clinical trials, recently conducted an audit of the transparency policies of pharmaceutical companies, finding them open enough on the surface — but beset with devils in the details.
-
Broad Consent Issues raised by SACHRP and Others
With broad consent, patients would have an easy and speedy opportunity to opt out of future research uses of their biospecimens. But if they didn’t opt out — and most people probably would agree to the research use of their specimens — then scientific progress could proceed without the consent roadblock.
-
FDA Lowers the Boom on Stem Cell Clinics
The FDA recently cracked down on two stem cell clinics for questionable research practices, including one clinic that was using smallpox vaccine as part of a treatment protocol.
-
NIH Considers Action on Pay-to-Participate Trials
Recent action by federal authorities against stem cell clinics charged with questionable practices appear to validate concerns raised by bioethicists like Leigh Turner, PhD, who recently warned that some stem cell clinics are charging research subjects exorbitant fees for participation in experimental treatments marketed as clinical trials on ClinicalTrials.gov.